Researchers at The Ottawa Hospital awarded 16 CIHR grants worth more than $8 million
February 3, 2025 - Researchers at The Ottawa Hospital are leading 16 new projects funded by the Canadian Institutes of Health Research (CIHR) through the most recent operating grant competition. |
Life, death and DNA tethering: research explores how the eye responds to stress
December 13, 2023 - New research from Dr. Pierre Mattar’s group sheds light on what happens inside retinal cells as they die, in hopes of finding new ways to help these light-sensing cells survive. |
“Dream team” of researchers tackles leading cause of vision loss
July 27, 2022 - Dr. Catherine Tsilfidis has assembled a world-class team to bring discoveries with game-changing potential to patients with retinal disease |
Meet brain and eye researcher Dr. Pierre Mattar
April 25, 2022 - Dr. Pierre Mattar is doing the groundwork needed to develop treatments for vision loss |
$2.4 M grant to help researchers develop gene and cell therapies for a leading cause of blindness
September 15, 2021 - A team led by Dr. Catherine Tsilfidis has received $2.4 M from the Ontario Research Fund to develop treatments for retinal diseases, a leading cause of blindness. |
The Ottawa Hospital awarded 13 grants worth $11.2 million from Canadian Institutes of Health Research
July 26, 2019 - Researchers at The Ottawa Hospital have been awarded 13 grants worth a total of $11.2 million from the Canadian Institutes of Health Research (CIHR). The new projects focus on areas such as cancer immunotherapy, hepatitis C infection, blood ... |
Scientist investigates how two gene mutations contribute to autism
April 24, 2019 - Dr. Pierre Mattar received $300,000 from the Simons Foundation to investigate how mutations of two genes contribute to autism. |
Chaos in the nucleus: research on eye cells could provide insight into degenerative diseases
August 22, 2018 - The nucleus of a cell is usually a highly organized structure, with more than a metre of DNA packaged very carefully into a tiny volume. A number of degenerative diseases, including Alzheimer’s, SCA7 and progeria are associated with a breakdown ... |
$870,000 to help develop stem cell treatments for septic shock, glaucoma, lung injury and muscle degeneration
May 9, 2018 - Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks to five new peer-reviewed research grants from the Ontario Institute for Regenerative Medi |
